Search

everythinglearnresearchcommunity

for

Search:↓

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Isotretinoin is a preferred treatment for severe acne, often leading to long-term improvement, but requires careful monitoring due to potential side effects.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Intralesional vitamin D3 is an effective and safe treatment for patchy alopecia areata with fewer side effects.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

A child's scalp infection was caused by a fungus not previously known to do so, but it was successfully treated.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Oral baricitinib is effective and safe for treating alopecia areata.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Ketoconazole improved symptoms of ACTH-independent Cushing syndrome despite inconclusive initial scans.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Topical tofacitinib is effective and safe for treating alopecia areata.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.